
One word among many on the back of the pack — and it decides what you actually bought.
The word most buyers never check
There is a detail printed on nearly every focus supplement on the shelf that almost nobody reads. It is not hidden. It is not in small print at the bottom. It is one word, sitting in the ingredients panel next to "choline", and it separates two quite different products sold at similar prices.
The inexpensive form
Choline bitartrate. It is genuine choline — the label is not lying — and it is the most common form on shelves for one reason: it costs very little to include.
The catch is the evidence. The evidence in healthy adults is one 2026 trial, and in it bitartrate did not show the cognitive benefit people buy it for.1 To be precise about what that study found: brain activation did change, but working-memory performance did not differ from placebo. That is a narrower finding than "it does nothing", and this desk states it narrowly rather than oversell it.
The researched form
Alpha-GPC. A highly bioavailable form of choline that can cross the blood–brain barrier,2 and the form behind most of the clinical research on choline and cognition.
It costs meaningfully more per gram. That is the whole reason the shelf looks the way it does.
What is actually on the shelf
None of this requires trust. It is printed on labels anyone can read:
| Product type | What the label says |
|---|---|
| A popular energy pouch | Alpha-GPC, 50 mg4 |
| A popular nootropic creamer | Alpha-GPC, 300 mg4 |
| Many capsule products | Choline bitartrate — not Alpha-GPC at all |
| Many labels of every kind | "Proprietary blend" — the amount is not disclosed |
And how much did the research use?
In healthy adults, trials have run at roughly servings of roughly 250–630 mg.3 Higher-dose trials do exist, at 800–1,200 mg — but they were run in people with diagnosed cognitive impairment, a population quite different from someone buying a focus supplement, and those numbers are not a target for a healthy adult.
So the checks, in order: the form word first. Then whether the milligrams are printed at all. Then whether the amount sits in the range studied in people like the reader.
Which is the actual point
Every row in that table can be verified in a couple of minutes on the manufacturers' own websites. That is what makes this argument different from most supplement marketing: it does not ask for belief. The label is checkable, and the invitation is to go and check it — including on this one.
Sources
- Dumas et al., 2026 — n=20 healthy adults, 1,650 mg choline bitartrate; no working-memory performance difference against placebo.
- Putri et al., Neuropsychiatric Disease and Treatment, 2026 — narrative review.
- Research in healthy adults: Nutrients 2024 (315 and 630 mg); a 2017 dose-comparison study (250 and 500 mg); a 2023 trial in cyclists (300 mg).
- Manufacturers' own published product pages, captured August 2026 and re-checked in the week of publication.
Full detail, including the population studied in each, is on the sources page.